Trademark: 79334573
Status Date
Tuesday, December 20, 2022
Registration Number
6927009
Registration Date
Tuesday, December 20, 2022
Filing Date
Tuesday, January 11, 2022
Published for Opposition
Tuesday, October 4, 2022
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
10 Medical apparatus for detecting cancer; Medical apparatus for monitoring blood glucose levels; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus for preventing or reversing heart failure; Medical apparatus and instruments for diagnostic radiopharmaceutical use; Medical apparatus for diagnosing or treating respiratory conditions; Medical apparatus for monitoring vital signs of patients; Medical apparatus and instruments for treating osteoarthritis and osteoporosis; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Medical apparatus, namely, infusion and injection devices for administering drugs; Medical apparatus for introducing pharmaceutical preparations into the human body
Apr 24, 2023
Final Decision Transaction Processed By Ib
Apr 5, 2023
Final Disposition Notice Sent To Ib
Apr 5, 2023
Final Disposition Processed
Mar 20, 2023
Final Disposition Notice Created, To Be Sent To Ib
Dec 20, 2022
Notice Of Registration Confirmation Emailed
Dec 20, 2022
Registered-Principal Register
Oct 4, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2022
Published For Opposition
Oct 2, 2022
Notification Processed By Ib
Sep 14, 2022
Notification Of Possible Opposition Sent To Ib
Sep 14, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 14, 2022
Notification Of Notice Of Publication E-Mailed
Aug 26, 2022
Approved For Pub - Principal Register
Aug 25, 2022
Teas/Email Correspondence Entered
Aug 25, 2022
Correspondence Received In Law Office
Aug 25, 2022
Teas Response To Office Action Received
Apr 24, 2022
Refusal Processed By Ib
Apr 6, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 6, 2022
Teas Change Of Correspondence Received
Apr 6, 2022
Teas Change Of Domestic Representatives Address
Apr 6, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 6, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 6, 2022
Teas Change Of Owner Address Received
Apr 1, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Apr 1, 2022
Refusal Processed By Mpu
Apr 1, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Mar 31, 2022
Non-Final Action Written
Mar 30, 2022
Assigned To Examiner
Mar 29, 2022
Application Filing Receipt Mailed
Mar 24, 2022
New Application Office Supplied Data Entered
Mar 21, 2022
Limitation From Original Application Entered
Feb 24, 2022
Sn Assigned For Sect 66a Subseq Desig From Ib
Trademark Alertz updated from USPTO on 2030-01-24
